RCUS Director bought 20,000 shares at $10.06; holdings +238.1%; cluster buy pattern with 2 others in 14 days.
KANEKO YASUNORI, as Director, purchased 20,000 shares at $10.06 on 2025-02-27, expanding his holdings by +238.1% from 8,400 to 28,400 shares. This transaction occurred as the stock trades 51.0% below its 52-week high of $20.18 and has declined 24.5% over 30 days and 36.0% over 90 days. Notably, two other insiders also executed purchases within the past 14 days, constituting a cluster buy pattern. The company is unprofitable (net income of $-92,000,000.00 in its most recent full fiscal year) despite showing strong annual revenue growth of +120.5%, and the $1.0B market cap company generated $48.0M in latest-quarter revenue, suggesting early-stage or transitional operations typical of biotech development profiles. The coordinated insider accumulation during a period of significant price decline, combined with multi-executive participation, presents a pattern worth monitoring for its implications regarding internal confidence or strategic positioning.